How Should the FDA Evaluate Psychedelic Medicine?
New England Journal of Medicine November 4, 2023 DOI: 10.1056/nejmp2308940 via OpenAlex
Summary
AI-generated from the abstractThe FDA's draft guidance on psychedelics research includes recommendations that may be contentious, even as mounting clinical evidence could lead to approval of new psychedelic medicines.
Study at a glance
| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Drug approval Alternative medicine Clinical research Pharmacology Pathology |
| Citations | 11 |
| Key finding | The FDA's draft guidance on psychedelics research includes recommendations that may be contentious. |
Abstract
Mounting clinical evidence could lead to the approval of new psychedelic medicines. The FDA’s draft guidance on psychedelics research includes several recommendations that may be contentious.